These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 17172122)
1. [Prophylactic effect of matrix metalloproteinase inhibitor on acute graft-versus-host disease in a murine model]. Gu Y; Liu CF Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):515-7. PubMed ID: 17172122 [TBL] [Abstract][Full Text] [Related]
2. [Experimental study of Tripterygium hypoglaucum (level) Hutch on preventing acute graft-versus-host disease in bone marrow transplantation mice]. Li S; Xu KL; Li ZY; Pan XY; Sun HY; Li DP; Cao J; Du B Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):727-30. PubMed ID: 18457261 [TBL] [Abstract][Full Text] [Related]
3. [Effect of delayed sequential bone marrow transplantation on acute graft-versus-host disease in major H-2 incompatible mouse transplantation]. Wang CL; Xu KL; Pan XY; Du B Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):92-6. PubMed ID: 18681308 [TBL] [Abstract][Full Text] [Related]
4. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation]. He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957 [TBL] [Abstract][Full Text] [Related]
5. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation. Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173 [TBL] [Abstract][Full Text] [Related]
6. [Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation by mycophenolate mofetil in a murine model]. Huang H; Zheng W; Lin M; Fu J; Zhang R Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):191-3. PubMed ID: 12133455 [TBL] [Abstract][Full Text] [Related]
7. [Prophylactic effect of TLR5 agonist flagellin on acute graft versus host disease after allogeneic hematopoietic stem cell transplantation and its mechanism]. Gong XD; Ma LM; Zhu L; Guo HM; Ren LS; Ren RR; Zhang HP; Wei F; Niu YY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):965-70. PubMed ID: 22931665 [TBL] [Abstract][Full Text] [Related]
8. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease]. Meng XJ; Lin MF; Cai Z Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961 [TBL] [Abstract][Full Text] [Related]
9. [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice]. Wang SB; Guo KY; Hu DM; Yin B Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):810-3. PubMed ID: 16793606 [TBL] [Abstract][Full Text] [Related]
10. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation. Toubai T; Tanaka J; Nishihira J; Ohkawara T; Hirate D; Kondo N; Tone S; Shono Y; Ibata M; Sugita J; Kato N; Miura Y; Iwao N; Ota S; Imamura M Transpl Immunol; 2006 Aug; 16(2):117-24. PubMed ID: 16860715 [TBL] [Abstract][Full Text] [Related]
11. Blocking L-selectin and alpha4-integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease. Li B; New JY; Yap EH; Lu J; Chan SH; Hu H Eur J Immunol; 2001 Feb; 31(2):617-24. PubMed ID: 11180127 [TBL] [Abstract][Full Text] [Related]
12. [ALA-PDT alleviates graft-versus-host disease in mice following allogenic bone marrow transplantation]. Ran HH; Pan KL; Zhang R; Wang YF Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):408-12. PubMed ID: 17052403 [TBL] [Abstract][Full Text] [Related]
13. [Experimental study on NK cells promoting donor marrow engraftment and hematopoietic reconstitution after MHC haploidentical BMT in mice]. Wang CY; Guo KY; Wu BY; Wu LX; Jiang ZY; Pan XH Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):290-2. PubMed ID: 15182539 [TBL] [Abstract][Full Text] [Related]
14. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease. Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664 [TBL] [Abstract][Full Text] [Related]
15. [Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation]. Yang K; Fan ZP; Liu QF; Zhang Y Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):537-41. PubMed ID: 18495584 [TBL] [Abstract][Full Text] [Related]
16. [Role of paternal veto cells in preventing graft-versus-host disease after HLA-haploidentical stem cell transplantation in mice]. Wang SB; Guo KY; Hu DM Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):79-81. PubMed ID: 18227034 [TBL] [Abstract][Full Text] [Related]
17. Achievement of target cyclosporine concentrations as a predictor of severe acute graft versus host disease in children undergoing hematopoietic stem cell transplantation and receiving cyclosporine and methotrexate prophylaxis. Punnett A; Sung L; Price V; Das P; Diezi M; Doyle J; Dupuis LL Ther Drug Monit; 2007 Dec; 29(6):750-7. PubMed ID: 18043472 [TBL] [Abstract][Full Text] [Related]
18. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia. Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755 [TBL] [Abstract][Full Text] [Related]
19. [Experimental study on promoting the engraftment of hematopoietic stem/progenitor cell by all-trans retinoic acid]. Mai HR; Huang SL; Xu HG; Fang JP; Wei J; Huang WG; Chen FY; Guo FF Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):393-7. PubMed ID: 14642173 [TBL] [Abstract][Full Text] [Related]
20. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]